Data / Form D filings / Silvergate Pharmaceuticals, Inc.
Silvergate Pharmaceuticals, Inc.: Form D filings
Silvergate Pharmaceuticals, Inc., a pharmaceuticals company in Greenwood Village, CO, filed 5 Form D notices with the SEC between 2011 and 2016. The latest, on October 18, 2016, reports $4.6 million sold of a $4.6 million offering to 10 investors.
Find out what Silvergate Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6251 GREENWOOD PLAZA BOULEVARD, SUITE 101, Greenwood Village, CO, 80111
- Phone
- (720) 266-4524
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1520642
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 18, 2016 | New notice | $4,600,000 | $4,600,000 | $0 | 10 | Oct 3, 2016 | sec.gov |
| Oct 14, 2015 | New notice | $4,600,000 | $1,600,000 | $3,000,000 | 9 | Oct 9, 2015 | sec.gov |
| Sep 12, 2014 | New notice | $1,000,000 | $1,000,000 | $0 | 7 | Aug 28, 2014 | sec.gov |
| Jun 14, 2013 | Amendment | $23,554,167 | $23,554,167 | $0 | 13 | May 2, 2011 | sec.gov |
| May 17, 2011 | New notice | $3,015,000 | $3,015,000 | $0 | 2 | May 2, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bhaskar Chaundhuri | Director | |
| Barry Barnard | Executive Officer | |
| Laura Medina | Executive Officer | |
| Frank Segrave | Executive Officer, Director | |
| Robert Mauro | Executive Officer | |
| Mark Parrish | Director | |
| Patrick Heron | Director | |
| Nathan Every | Director | |
| Michael Beckloff | Executive Officer |
Every Form D from the week of Oct 17, 2016 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Silvergate Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.